Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.

about

Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.

Item

http://www.wikidata.org/entity/Q40468778

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Association of β1-Adrenergic, ...... nvalvular Atrial Fibrillation.

@en

type

Item

label

Association of β1-Adrenergic, ...... nvalvular Atrial Fibrillation.

@en

prefLabel

Association of β1-Adrenergic, ...... nvalvular Atrial Fibrillation.

@en

P1476

Association of β1-Adrenergic, ...... nvalvular Atrial Fibrillation.

@en

P2093

Bing Hu

http://www.w3.org/2001/XMLSchema#string

Jie Sun

http://www.w3.org/2001/XMLSchema#string

L I Feng

http://www.w3.org/2001/XMLSchema#string

Sha Li

http://www.w3.org/2001/XMLSchema#string

Tong Liu

http://www.w3.org/2001/XMLSchema#string

Yanxiang Sun

http://www.w3.org/2001/XMLSchema#string

Zidi Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism

Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy

β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.

beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.

The emerging role of biomarkers in atrial fibrillation.

Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.

Autoantibodies of β-adrenergic and M2 cholinergic receptors: atrial fibrillation in hyperthyroidism

Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.

Autoantibodies and cardiac arrhythmias.

Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker.

P304

1379-1387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PACE.12976

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27862036

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody